Women who have undergone uterine artery embolization (UAE) to treat fibroids have a significantly higher risk of delivery by cesarean section as well as an increase in preterm delivery, postpartum hemorrhage, miscarriage, and lower pregnancy rates compared to the general obstetric population, according to study findings published in the November issue of the American Journal of Obstetrics and Gynecology
Women who have undergone uterine artery embolization (UAE) to treat fibroids have a significantly higher risk of delivery by cesarean section as well as an increase in preterm delivery, postpartum hemorrhage, miscarriage, and lower pregnancy rates compared to the general obstetric population, according to study findings published in the November issue of the American Journal of Obstetrics and Gynecology.
Woodruff J. Walker, FRCR, and a colleague at the Royal Surrey County Hospital in Guildford, UK, conducted a study of 56 completed pregnancies from a cohort of 1,200 women who had undergone UAE.
While 33 (58.9%) of the pregnancies were successful, six of them (18.2%) were premature and 24 (72.7%) were delivered by CD. There were 13 elective CD and nine were due to fibroids. In six cases (18.2%) there was postpartum hemorrhage. In all there were 17 (30.4%) miscarriages, three terminations, two stillbirths, and one ectopic pregnancy.
Walker WJ, McDowell SJ. Pregnancy after uterine artery embolization for leiomyomata: a series of 56 completed pregnancies. Am J Obstet Gynecol. 2006;195:1266-1271.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More